InVivo Therapeutics Holdings Corp. Press Releases

NVIV 
$0.6675
*  
0.0175
2.55%
Get NVIV Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading NVIV now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

InVivo Therapeutics to Present at the Stem Cell Meeting on the Mesa
8/21/2014 8:00:00 AM - Business Wire

Shapiro Haber & Urmy LLP Announces It Filed the Securities Fraud Class Action Lawsuit Against InVivo Therapeutics Holdings Corp.
8/15/2014 6:22:00 PM - Business Wire

InVivo Therapeutics Receives Notice of Allowance on Patent Covering Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells
8/11/2014 8:00:00 AM - Business Wire

Investigation on Behalf of InVivo Therapeutics Holdings Corp. Investors Announced by Kirby McInerney LLP
8/6/2014 4:39:00 PM - Business Wire

InVivo Therapeutics Reports 2014 Second Quarter Financial Results and Business Update
8/6/2014 4:30:00 PM - Business Wire

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against InVivo Therapeutics Holdings Corp.
8/5/2014 8:00:00 PM - GlobeNewswire

InVivo Therapeutics CEO Mark Perrin in Featured Interview on The Wall Street Transcript
8/5/2014 4:30:00 PM - Business Wire

Shapiro Haber & Urmy LLP Announces It Filed the Securities Fraud Class Action Lawsuit Against InVivo Therapeutics Holdings Corp. (NVIV)
8/5/2014 1:35:00 PM - PR Newswire

InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting
8/1/2014 8:00:00 AM - Business Wire

InVivo Therapeutics Appoints Christopher McNulty as Vice President, Business Development & Investor Relations
7/1/2014 8:30:00 AM - Business Wire

InVivo Therapeutics to Present at 4th International Neural Regeneration Symposium in China
6/30/2014 8:30:00 AM - Business Wire

InVivo Therapeutics Announces Barrow Neurological Institute As Third Clinical Trial Site for Neuro-Spinal Scaffold
6/26/2014 8:30:00 AM - Business Wire

InVivo Therapeutics Announces New Responsibilities for Senior Management Team Members
6/24/2014 4:30:00 PM - Business Wire

InVivo Therapeutics Announces Realignment of R&D Strategy
6/23/2014 4:30:00 PM - Business Wire

InVivo Therapeutics Appoints Steven McAllister as CFO
6/19/2014 8:00:00 AM - Business Wire